Catalyst Wire Dossier Catalyst Wire Dossier

MuGard

· Access Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MuGard, covering 2013-09-12 to 2013-09-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients [Phase 4]

See pricing